文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

急性呼吸窘迫综合征后第一年的疲劳症状

Fatigue Symptoms During the First Year Following ARDS.
PubMed 文献 · Chest · 2020-04-15
一句话结论ARDS存活者中超过三分之二在出院后第一年报告有临床意义的疲劳症状,且常与躯体、认知和心理健康损害共存。

该分析是ARDSNet长期结局研究(ALTOS)的一部分,在美国38家医院前瞻性纳入ARDS存活者。采用年龄和性别校正的时间平均随机效应回归模型,评估验证版慢性病治疗功能评估-疲劳量表与患者及危重症变量、以及6个月和12个月时躯体、认知和心理健康状态的关系。结果显示,6个月和12个月时分别有70%(501/711)和66%(436/659)的存活者报告有临床意义的疲劳症状;6个月时疲劳患病率(70%)高于躯体功能受损(50%)、焦虑(42%)和抑郁(36%)。危重症变量(如疾病严重程度、住院时间)与疲劳症状关联很小。作者认为,临床医生在患者报告疲劳时,应评估和管理其躯体、认知和心理健康状态。

要点

  • ARDS存活者6个月时临床显著疲劳患病率为70%(501/711),12个月时为66%(436/659)。
  • 6个月时疲劳患病率(70%)高于躯体功能受损(50%)、焦虑(42%)和抑郁(36%)。
  • 46%的存活者同时报告躯体功能受损和疲劳,27%同时存在焦虑、抑郁和疲劳。
  • 男性及ARDS前有工作者疲劳程度较轻;危重症变量(如疾病严重程度、住院时间)与疲劳症状关联很小。
  • 6个月和12个月时,躯体、认知和心理健康症状越差与疲劳越重相关。

适用人群与场景

  • 美国38家医院前瞻性纳入的ARDS存活者。
  • 分析人群为ALTOS研究中的ARDS存活者,于6个月和12个月时评估。

研究设计与关键结果

  • 研究类型为前瞻性研究(ALTOS),在美国38家医院开展。
  • 6个月时501/711(70%)和12个月时436/659(66%)的ARDS存活者报告有临床意义的疲劳症状。
  • 分别有41%和28%报告临床重要改善和恶化(n=638)。
  • 6个月时疲劳患病率(70%)高于躯体功能受损(50%)、焦虑(42%)和抑郁(36%)。
  • 46%报告躯体功能受损和疲劳共存,27%报告焦虑、抑郁和疲劳共存。
  • 男性和ARDS前有工作者疲劳程度较轻;危重症变量(如疾病严重程度、住院时间)与疲劳症状关联很小。
  • 6个月和12个月随访时,躯体、认知和心理健康症状越差与疲劳越重相关。

证据类型、等级与局限

  • 证据类型:前瞻性研究(ALTOS),采用年龄和性别校正的时间平均随机效应回归模型。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,由于疲劳常与躯体、认知和心理健康损害共存,临床医生在ARDS存活者报告疲劳时,应评估和管理其躯体、认知和心理健康状态。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Fatigue is commonly reported by ARDS survivors, but empirical data are scarce.

RESEARCH QUESTION: This study evaluated fatigue prevalence and associated variables in a prospective study of ARDS survivors.

STUDY DESIGN AND METHODS: This analysis is part of the ARDSNet Long-Term Outcomes Study (ALTOS) conducted at 38 US hospitals. Using age- and sex-adjusted, time-averaged random effects regression models, we evaluated associations between the validated Functional Assessment of Chronic Illness Therapy-Fatigue Scale with patient and critical illness variables, and with physical, cognitive, and mental health status at 6 and 12 months following ARDS.

RESULTS: Among ARDS survivors, 501 of 711 (70%) and 436 of 659 (66%) reported clinically significant symptoms of fatigue at 6 and 12 months, respectively, with 41% and 28% reporting clinically important improvement and worsening (n = 638). At 6 months, the prevalence of fatigue (70%) was greater than that of impaired physical functioning (50%), anxiety (42%), and depression (36%); 46% reported both impaired physical function and fatigue, and 27% reported co-existing anxiety, depression, and fatigue. Fatigue was less severe in men and in those employed prior to ARDS. Critical illness variables (eg, illness severity, length of stay) had little association with fatigue symptoms. Worse physical, cognitive, and mental health symptoms were associated with greater fatigue at both the 6- and 12-month follow-up.

INTERPRETATION: During the first year following ARDS, more than two-thirds of survivors reported clinically significant fatigue symptoms. Due to frequent co-occurrence, clinicians should evaluate and manage survivors' physical, cognitive, and mental health status when fatigue is endorsed.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Neufeld KJ, Leoutsakos JS, Yan H, et al. Fatigue Symptoms During the First Year Following ARDS. Chest. 2020. PMID: 32304774. doi:10.1016/j.chest.2020.03.059

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。